ZFIN Image: Park et al., 2020, Figure 2

Image

Figure Caption

Figure 2 B-ALL regress with DXM or IR treatments.

(A) B-ALL in rag2:hMYC fish treated with DXM for 9 days (n = 19). Post-treatment and relapsed images were obtained on days 9 and 28, respectively. Every (19/19) B-ALL regressed after DXM, but 11/19 (58%) B-ALL relapsed by day 28 (19 days after DXM withdrawal). (B) B-ALL in rag2:hMYC fish treated with IR (n = 13). Post-treatment and relapsed images were obtained on days 7 (i. e., 2 days after the 2nd IR dose) and 23, respectively. Every B-ALL (13/13) regressed after IR, but 100% recurred within 3 weeks of the 2nd IR dose. Upon relapse, flow cytometric testing (See Figure 1B) was used to verify that each relapse was GFP^lo B-ALL. Images of rag2:hMYC, lck:GFP fish (top 5 animals) have had brightness enhanced to facilitate visualization of dim B-ALL. Images of the rag2:hMYC, cd79a:GFP fish (lowest animal) are unmodified.

Figure Data

Phenotype details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Oncotarget